Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.

Bullboard Post History

by kingpost


PMN

RE:article from The Street ....

"good one to watch as they are using the similar principles that PMN is...

March 14, 2017

PMN

RE:RE:PMN and CNS targeting ...

silent and 101 ... you guys talk quite confidently.... I would caution any...

February 15, 2017

PMN

PMN and CNS targeting ...

Firstly, I currently have no position in PMN and do not think it is...

February 14, 2017

PMN

RE:RE:Merck Base inhibitor trial deemed a fail today...

Merch EPOCH trial after hours news today: http://www.marketwatch.com/story...

February 14, 2017

PMN

Merck Base inhibitor trial deemed a fail today...

The trial has been stopped .... A couple of other trials are still pursuing...

February 14, 2017

PMN

Why did LLY drop its AB drug 2 weeks before conference..

We will se what is up with LLY at the Dec SanDiego conference  but it...

November 30, 2016

PMN

thoughts on Lilly's results......

I like  the PMN tech , and am very hopeful it succeeds; but I am...

November 27, 2016

ARLZQ

Bayer bus dev mgr should be fired if he is not on ARZ now..

I am not hoping for a buy out but I would be shocked if Bayer (and likely...

November 16, 2016

ARLZQ

Institutional buying is impressive...

https://fintel.io/sob/us/arlz

November 15, 2016

V.AVCR

US generic news...

Mylan N.V.'s (MYL -5%) U.S. launch of its generic version...

June 24, 2016

V.AVCR

Teva sells 15 generics to satisfy FTC rules ...

Impax Laboratories (NASDAQ:IPXL) acquires a group of 15 generic...

June 21, 2016

V.AVCR

Bashing against co fundamentals ok... even good...

The trouble is, and we see it here now, is some take advantage of this...

May 5, 2016

V.AVCR

The business plan separates NPH from all others...

The OTC products with their margins are key, the generics with their broad...

May 3, 2016

V.AVCR

management comp...

--in the real world pay is based typically on a combination of what others in...

May 1, 2016

V.AVCR

Proposal to award escrow share comp to Arun & key management

Will try to post my proposal this weekend....but am thinking Arun and key...

April 30, 2016

V.AVCR

SDM yes they can finance just like private companies do...

They do not need the money from the warrants at .50 and they certainly do not...

April 29, 2016

V.AVCR

image from herald ... who is running the speed control...

 800 × 508 - dailyherald.com    first...

April 27, 2016

V.AVCR

RE:Not sure what we can complain

Very accurate and well said summary post Taman1 .... you have two worlds here...

April 27, 2016

V.AVCR

Generic Insulin being developed in china with Lannett JV..

Lannett Company (NYSE:LCI) announces plans to co-develop a generic...

April 26, 2016

V.AVCR

trajectory bodes well for possible multiples valued at...

In general when the growth rate of a company equals the P/E multiple most...

April 25, 2016